Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 200 Total
ATGL - Alpha Technology Group Limited - Stock Price Chart
TickerATGL [NASD]
CompanyAlpha Technology Group Limited
CountryHong Kong
IndustrySoftware - Infrastructure
Market Cap49.87MEPS (ttm)-0.07
P/E-EPS this Y-171.50%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S45.34EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q55.90%
Insider Own71.97%Inst Own0.06%
Insider Trans0.00%Inst Trans-
Short Float0.37%Earnings-
Analyst Recom-Target Price-
Avg Volume22.84K52W Range1.70 - 31.57
Feb-01-24 08:00AM Alpha Technology Group Limited Reports 2023 Financial Year Results (PR Newswire) +7.11%
Nov-21-23 09:51AM Alpha Technology Group Limited Announces Exercise of the Underwriter's Over-Allotment Option (GlobeNewswire) -27.31%
Nov-03-23 10:30AM Alpha Technology Debuts on Nasdaq as the First AI IT Service Company from Hong Kong (GlobeNewswire) +17.80%
Nov-02-23 10:50AM Alpha Technology Group Limited Announces Closing of Its Initial Public Offering (GlobeNewswire) +17.86%
Oct-31-23 01:01AM Alpha Technology Group Limited Announces Pricing of Its Initial Public Offering (GlobeNewswire)
CYCC - Cyclacel Pharmaceuticals Inc - Stock Price Chart
TickerCYCC [NASD]
CompanyCyclacel Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.80MEPS (ttm)-27.02
P/E-EPS this Y49.98%
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.13%
P/S6.66EPS next 5Y-
P/B3.70EPS Q/Q30.27%
Dividend-Sales Q/Q-
Insider Own8.89%Inst Own7.12%
Insider Trans7.27%Inst Trans-
Short Float3.20%EarningsMar 19/a
Analyst Recom2.00Target Price11.00
Avg Volume466.82K52W Range1.30 - 13.20
Apr-30-24 02:37PM Top Midday Gainers (MT Newswires) +55.88%
07:47AM Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? (InvestorPlace)
07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
07:00AM Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Apr-01-24 09:15AM Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer (GlobeNewswire)
Mar-20-24 10:05AM Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-19-24 08:53PM CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023 (InvestorPlace) -6.37%
04:05PM Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-13-24 04:05PM Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-07-24 09:15AM Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 (GlobeNewswire) +5.06%
SMFL - Smart for Life Inc - Stock Price Chart
TickerSMFL [NASD]
CompanySmart for Life Inc
CountryUSA
IndustryPackaged Foods
Market Cap0.82MEPS (ttm)-1221.87
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.07EPS next 5Y-
P/B0.30EPS Q/Q76.01%
Dividend-Sales Q/Q-48.66%
Insider Own1.26%Inst Own1.15%
Insider Trans0.00%Inst Trans-
Short Float7.20%Earnings-
Analyst Recom3.00Target Price504.00
Avg Volume678.10K52W Range2.28 - 478.17
Apr-29-24 08:30AM Smart For Life to Attend National Pet Food Forum on April 29 to May 2 (GlobeNewswire)
Apr-26-24 08:00AM Smart for Life Announces Availability of a White Paper on the Nutraceuticals Industry (GlobeNewswire) +15.71%
Apr-24-24 08:30AM Smart for Life Appoints Prominent Industry Executive David Trosin to Company's Advisory Board (GlobeNewswire) -6.84%
Apr-23-24 05:30PM Smart for Life Announces the Successful Completion of Restructuring Program (GlobeNewswire) +7.59%
Apr-18-24 02:00PM Smart for Life Announces the Appointment of Heather Granato to the Company's Board of Directors (GlobeNewswire)
12:01PM Smart for Life Announces 1-for-7 Reverse Stock Split (GlobeNewswire)
Apr-16-24 10:39AM Smart for Life to Sponsor Industry Event What's Up with Supps at SupplySide East (GlobeNewswire)
Apr-08-24 04:17PM Why Is Smart for Life (SMFL) Stock Up 150% Today? (InvestorPlace) +38.88%
01:14PM Smart for Life Releases Corporate Video on Definitive Agreement to Acquire Purely Optimal Nutrition (GlobeNewswire)
10:00AM EXCLUSIVE: Smart for Life Announces Strategic Acquisition of Purely Optimal, Eyes Revenue Growth (Benzinga)
WGS - GeneDx Holdings Corp - Stock Price Chart
TickerWGS [NASD]
CompanyGeneDx Holdings Corp
CountryUSA
IndustryHealth Information Services
Market Cap444.67MEPS (ttm)-5.25
P/E-EPS this Y65.21%
Forward P/E-EPS next Y62.29%
PEG-EPS past 5Y-
P/S2.00EPS next 5Y-
P/B2.15EPS Q/Q74.45%
Dividend-Sales Q/Q44.70%
Insider Own37.76%Inst Own42.52%
Insider Trans-7.23%Inst Trans-11.90%
Short Float6.59%EarningsApr 29/a
Analyst Recom2.00Target Price11.38
Avg Volume305.98K52W Range1.16 - 12.57
Apr-30-24 07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) +55.18%
Apr-29-24 08:55PM WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:50PM GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM GeneDx Reports First Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Apr-23-24 08:30AM GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset (GlobeNewswire) +15.50%
Apr-04-24 04:05PM GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 (GlobeNewswire)
Mar-21-24 09:55AM Here's Why GENEDX HOLDINGS (WGS) Could be Great Choice for a Bottom Fisher (Zacks) +7.87%
Mar-14-24 08:30AM GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics (GlobeNewswire)
Feb-26-24 04:05PM GeneDx to Participate in 44th Annual Cowen Health Care Conference (GlobeNewswire)
Feb-21-24 08:33AM GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2023 Earnings Call Transcript (Insider Monkey) +32.63%
KAVL - Kaival Brands Innovations Group Inc - Stock Price Chart
TickerKAVL [NASD]
CompanyKaival Brands Innovations Group Inc
CountryUSA
IndustryTobacco
Market Cap12.73MEPS (ttm)-3.79
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-252.44%
P/S0.92EPS next 5Y-
P/B1.08EPS Q/Q31.77%
Dividend-Sales Q/Q27.14%
Insider Own70.51%Inst Own1.86%
Insider Trans0.00%Inst Trans-82.26%
Short Float11.03%EarningsMar 27/b
Analyst Recom1.00Target Price5.00
Avg Volume2.47M52W Range1.11 - 20.27
Mar-27-24 08:30AM Kaival Brands Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update (GlobeNewswire) -13.54%
Mar-21-24 07:49AM Why Is Kaival Brands Innovations (KAVL) Stock Up 77% Today? (InvestorPlace) +118.80%
Feb-14-24 04:15PM Kaival Brands Provides Business Update in Letter to Shareholders (GlobeNewswire)
Jan-29-24 08:15AM Kaival Brands Partner Bidi Vapor to Contest FDA Denial of 'Classic' Tobacco-Flavored ENDS (GlobeNewswire) +6.81%
Jan-23-24 08:15AM Kaival Brands Innovations Group Announces Reverse Stock Split (GlobeNewswire) -6.18%
Dec-28-23 08:30AM Kaival Brands Appoints Executive Chairman Barry Hopkins as Interim Chief Executive Officer and President (GlobeNewswire) +9.10%
Dec-07-23 08:30AM Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel (GlobeNewswire) +16.94%
Nov-29-23 11:25AM Kaival Brands, Exclusive Distributor of Bidi Vapor Products to the E-Cigarette and Vape Industry, Featured in InvestmentPitch Media Video (Newsfile) +22.67%
Nov-13-23 08:15AM Kaival Brands Expands Senior Management Team with the Appointment of Barry Hopkins as Executive Chairman (GlobeNewswire)
Nov-07-23 08:15AM Kaival Brands Leads the Way in Compliance as FDA Ramps Up Enforcement of Illicit Vape Products (GlobeNewswire)
NRXP - NRX Pharmaceuticals Inc - Stock Price Chart
TickerNRXP [NASD]
CompanyNRX Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap24.69MEPS (ttm)-1.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-235.69%
Dividend-Sales Q/Q-
Insider Own20.20%Inst Own4.20%
Insider Trans0.00%Inst Trans-
Short Float6.69%EarningsMar 28/b
Analyst Recom1.00Target Price20.00
Avg Volume234.19K52W Range2.21 - 12.00
Apr-30-24 08:30AM NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression (PR Newswire) -27.32%
Apr-18-24 08:56AM Why Is NRX Pharmaceuticals (NRXP) Stock Down 29% Today? (InvestorPlace) -27.75%
08:32AM NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement (PR Newswire)
08:30AM NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock (PR Newswire)
Apr-17-24 04:45PM NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock (PR Newswire)
08:30AM NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections (PR Newswire)
Apr-15-24 08:30AM NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine) (PR Newswire)
Apr-08-24 08:30AM NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression (PR Newswire)
Apr-04-24 12:00PM NRx Pharmaceuticals (NRXP) Upgraded to Strong Buy: Here's What You Should Know (Zacks) +9.70%
Apr-02-24 10:33AM NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcript (Insider Monkey)
OCG - Oriental Culture Holding Ltd - Stock Price Chart
TickerOCG [NASD]
CompanyOriental Culture Holding Ltd
CountryHong Kong
IndustryInternet Retail
Market Cap5.57MEPS (ttm)-0.62
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y4.29%
P/S3.55EPS next 5Y-
P/B0.12EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own31.54%Inst Own1.58%
Insider Trans0.00%Inst Trans18.62%
Short Float0.93%Earnings-
Analyst Recom-Target Price-
Avg Volume68.98K52W Range0.85 - 3.94
Nov-17-23 04:30PM Oriental Culture Holding LTD Announces First Half Year of 2023 Unaudited Financial Results (GlobeNewswire)
Nov-02-23 08:30AM Oriental Culture Holding LTD. Regains Compliance with Nasdaq's Minimum Bid Price Rule (GlobeNewswire)
Oct-16-23 04:30PM Oriental Culture Holding LTD. Announces Extraordinary General Meeting Results and Share Consolidation (GlobeNewswire) -9.06%
May-12-23 08:30AM Oriental Culture Holding LTD. Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule (GlobeNewswire)
May-04-23 06:15AM Oriental Culture Holding Full Year 2022 Earnings: EPS: US$0.15 (vs US$0.56 in FY 2021) (Simply Wall St.)
Apr-05-23 07:00AM Outcrop Silver Reports Exceptional Metallurgical Results - Confirming Recoveries of 93.4% Silver and 96.7% Gold (PR Newswire) +6.06%
Mar-14-23 07:00AM OUTCROP SILVER INTERSECTS 5.89 METRES TRUE WIDTH OF 426 GRAMS EQUIVALENT SILVER PER TONNE AND 2.72 METRES TRUE WIDTH OF 445 GRAMS EQUIVALENT SILVER PER TONNE EXPANDING THE MEGAPOZO SHOOT AT SANTA ANA (PR Newswire)
Dec-23-22 04:45PM Oriental Culture Holding LTD Announces First Half Year of 2022 Unaudited Financial Results (GlobeNewswire)
Nov-15-22 04:15PM Oriental Culture Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire) +8.04%
Sep-16-22 06:06AM 3 Best NFT Stocks to Buy Now (InvestorPlace)
EQ - Equillium Inc - Stock Price Chart
TickerEQ [NASD]
CompanyEquillium Inc
CountryUSA
IndustryBiotechnology
Market Cap52.52MEPS (ttm)-0.38
P/E-EPS this Y88.82%
Forward P/E-EPS next Y-876.47%
PEG-EPS past 5Y18.79%
P/S1.46EPS next 5Y-
P/B2.33EPS Q/Q-182.53%
Dividend-Sales Q/Q-41.55%
Insider Own51.18%Inst Own7.25%
Insider Trans0.00%Inst Trans2.51%
Short Float2.31%EarningsMar 25/a
Analyst Recom1.00Target Price6.75
Avg Volume370.60K52W Range0.45 - 3.25
Apr-03-24 08:00AM Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.88%
Apr-01-24 10:15AM Equillium's lupus drug improves kidney biomarker, teeing up opt-in decision from Ono (FierceBiotech.com) -8.66%
08:00AM Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis (Business Wire)
Mar-25-24 09:53PM EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -13.48%
05:10PM Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:01PM Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights (Business Wire)
Mar-22-24 08:00AM Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference (Business Wire)
Jan-29-24 04:07AM 15 Cash-Rich Penny Stocks Hedge Funds Are Buying (Insider Monkey)
Dec-21-23 09:52AM Equillium swaps multi-cytokine inhibitor for oral option after underwhelming phase 2 data (FierceBiotech.com) -9.57%
08:00AM Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease (Business Wire)
LEXX - Lexaria Bioscience Corp - Stock Price Chart
TickerLEXX [NASD]
CompanyLexaria Bioscience Corp
CountryCanada
IndustryBiotechnology
Market Cap39.83MEPS (ttm)-1.13
P/E-EPS this Y53.96%
Forward P/E-EPS next Y4.30%
PEG-EPS past 5Y18.43%
P/S117.15EPS next 5Y-
P/B5.87EPS Q/Q79.57%
Dividend-Sales Q/Q42.89%
Insider Own12.93%Inst Own9.93%
Insider Trans0.00%Inst Trans9.21%
Short Float3.88%Earnings-
Analyst Recom1.00Target Price10.00
Avg Volume499.39K52W Range0.65 - 6.85
Apr-30-24 03:40PM Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance (ACCESSWIRE) +25.61%
Apr-16-24 09:10AM Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study (ACCESSWIRE) +16.08%
Apr-09-24 09:52PM LEXX Stock Earnings: Lexaria Bioscience Beats EPS for Q2 2024 (InvestorPlace) -8.78%
Apr-02-24 09:00AM Lexaria Awarded New Patents (ACCESSWIRE)
Mar-21-24 09:20AM Lexaria to Present at The LD Micro Invitational XIV (Newsfile) -7.03%
Mar-14-24 09:20AM Lexaria Appoints Nelson Cabatuan as Chief Financial Officer (ACCESSWIRE) -12.50%
Mar-07-24 09:05AM Lexaria Awards Contract For Next GLP-1 Human Pilot Study (ACCESSWIRE) +11.61%
Mar-05-24 09:05AM Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1 (ACCESSWIRE) +12.67%
Mar-04-24 09:15AM 7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study (ACCESSWIRE)
Mar-01-24 08:20AM Lexaria Announces FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial (ACCESSWIRE) -15.36%
MAIA - MAIA Biotechnology Inc - Stock Price Chart
TickerMAIA [AMEX]
CompanyMAIA Biotechnology Inc
CountryUSA
IndustryBiotechnology
Market Cap60.30MEPS (ttm)-1.45
P/E-EPS this Y-6.02%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-25.01%
P/S-EPS next 5Y-
P/B104.23EPS Q/Q2.67%
Dividend-Sales Q/Q-
Insider Own24.79%Inst Own3.85%
Insider Trans13.83%Inst Trans114.80%
Short Float5.07%EarningsNov 07/b
Analyst Recom1.00Target Price14.00
Avg Volume347.20K52W Range0.82 - 3.48
Apr-30-24 08:08AM MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement (Business Wire) -8.72%
Apr-29-24 08:08AM MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement (Business Wire) +9.18%
Apr-23-24 08:51AM MAIA Biotechnology Announces $1.00 Million Private Placement (Business Wire) +8.85%
Apr-05-24 08:01AM MAIA Biotechnology to Present at Two Investor Conferences in April 2024 (Business Wire) +6.82%
Mar-28-24 03:00PM MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero (Business Wire) -11.29%
Mar-26-24 03:00PM MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement (Business Wire)
08:01AM MAIA Biotechnology Announces $1.33 Million Private Placement (Business Wire)
Mar-22-24 03:00PM MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement (Business Wire) +8.76%
Mar-21-24 03:00PM MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board (Business Wire) +17.58%
Mar-16-24 01:49AM Director Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA) (GuruFocus.com)
12345678910⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.